Yorktown Management & Research Company’s Legend Biotech LEGN Stock Holding History

Yorktown Management & Research Company’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Buy	+14,250	New	+$384K	0.25%	152

Other funds holding LEGN

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Texas Permanent School Fund Austin, Texas $2.26B AUM 7.02% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

Yorktown Management & Research Company's LEGN Position: Q2 2026 in Review

Yorktown Management & Research Company opened a new position in Legend Biotech (LEGN) in Q2 2026: 14,250 shares worth $412K. The stake represents 0.25% of the portfolio and ranks #152 among its holdings.

31 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Yorktown Management & Research Company held 14,250 shares of Legend Biotech worth $412K as of Q2 2026.
Legend Biotech was a new Yorktown Management & Research Company position in Q2 2026.
Legend Biotech made up 0.25% of Yorktown Management & Research Company's portfolio in Q2 2026, its #152 holding.
31 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.